ArticleCureus2024
Systemic Vasculitis Post-COVID-19: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vasculitis is one of the complications of COVID. Coronavirus may trigger or exacerbate autoimmune diseases, such as systemic vasculitis. We present the case of an elderly individual with a medical history that includes recurrent urinary tract infections, hyperlipidemia, essential hypertension, and peripheral vascular disease. Doctors suspected vasculitis due to declining renal function, clinical condition, and serological findings of the patient. His serum tested positive for antinuclear antibodies. A kidney biopsy was deemed necessary due to the unclear cause of his renal insufficiency. The biopsy revealed focal necrotizing and crescentic glomerulonephritis (GN), a pauci-immune type. It is essential to learn more about COVID-19 and its related complications. This case highlights the difficulties of COVID-19, leading to focal necrotizing and crescentic GN. Maintaining a broad differential is essential while treating a patient who has recovered from the initial infection. This research is important because it will help clinicians to identify this perspective while treating patients. We also review some related articles on the association of COVID-19 with vasculitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.